Compare FDC LTD. with STRIDES PHARMA SCIENCE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs STRIDES PHARMA SCIENCE - Comparison Results

STRIDES PHARMA SCIENCE 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. STRIDES PHARMA SCIENCE FDC LTD./
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 16.3 14.5 112.2% View Chart
P/BV x 2.2 0.9 257.1% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 FDC LTD.   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    FDC LTD.
Mar-18
STRIDES PHARMA SCIENCE
Mar-18
FDC LTD./
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs3191,147 27.8%   
Low Rs164642 25.5%   
Sales per share (Unadj.) Rs61.6317.2 19.4%  
Earnings per share (Unadj.) Rs9.97.8 126.8%  
Cash flow per share (Unadj.) Rs12.025.1 47.7%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs73.2274.3 26.7%  
Shares outstanding (eoy) m174.4089.50 194.9%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x3.92.8 138.9%   
Avg P/E ratio x24.3114.0 21.3%  
P/CF ratio (eoy) x20.235.7 56.5%  
Price / Book Value ratio x3.33.3 101.2%  
Dividend payout %025.5 0.0%   
Avg Mkt Cap Rs m42,11880,058 52.6%   
No. of employees `0005.52.5 220.6%   
Total wages/salary Rs m2,1674,341 49.9%   
Avg. sales/employee Rs Th1,943.711,325.8 17.2%   
Avg. wages/employee Rs Th391.71,731.4 22.6%   
Avg. net profit/employee Rs Th313.7280.1 112.0%   
INCOME DATA
Net Sales Rs m10,75128,394 37.9%  
Other income Rs m510941 54.2%   
Total revenues Rs m11,26029,334 38.4%   
Gross profit Rs m2,2673,965 57.2%  
Depreciation Rs m3511,540 22.8%   
Interest Rs m141,962 0.7%   
Profit before tax Rs m2,4111,403 171.8%   
Minority Interest Rs m-50-   
Prior Period Items Rs m0-168 0.0%   
Extraordinary Inc (Exp) Rs m0-436 0.0%   
Tax Rs m67197 689.8%   
Profit after tax Rs m1,735702 247.1%  
Gross profit margin %21.114.0 151.0%  
Effective tax rate %27.86.9 401.5%   
Net profit margin %16.12.5 652.7%  
BALANCE SHEET DATA
Current assets Rs m7,21324,836 29.0%   
Current liabilities Rs m2,10418,993 11.1%   
Net working cap to sales %47.520.6 230.9%  
Current ratio x3.41.3 262.2%  
Inventory Days Days5471 76.8%  
Debtors Days Days28113 24.4%  
Net fixed assets Rs m6,86534,289 20.0%   
Share capital Rs m175895 19.6%   
"Free" reserves Rs m12,58623,651 53.2%   
Net worth Rs m12,76124,546 52.0%   
Long term debt Rs m615,513 0.0%   
Total assets Rs m15,04165,437 23.0%  
Interest coverage x173.21.7 10,100.1%   
Debt to equity ratio x00.6 0.1%  
Sales to assets ratio x0.70.4 164.7%   
Return on assets %11.64.1 285.6%  
Return on equity %13.62.9 475.3%  
Return on capital %19.06.9 275.0%  
Exports to sales %12.30-   
Imports to sales %00-   
Exports (fob) Rs m1,327NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,88915,697 12.0%   
Fx outflow Rs m0735 0.0%   
Net fx Rs m1,88914,962 12.6%   
CASH FLOW
From Operations Rs m1,4981,871 80.1%  
From Investments Rs m2015,826 3.5%  
From Financial Activity Rs m-1,694-10,157 16.7%  
Net Cashflow Rs m10-2,615 -0.4%  

Share Holding

Indian Promoters % 68.9 27.7 248.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 37.8 12.4%  
FIIs % 7.5 8.6 87.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 25.9 73.4%  
Shareholders   23,730 56,241 42.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   DR. DATSONS LABS  BIOCON   FULFORD INDIA  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends above 39,000-Mark; Automobile and Banking Stocks Witness Buying(Closing)

Extending gains to the fifth day, Indian share markets rose sharply during the afternoon session and ended on a strong note.

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY20); Net Profit Up 1048.1% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 432 m (up 1048.1% YoY). Sales on the other hand came in at Rs 7 bn (up 3.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (4QFY19); Net Profit Up 7919.8% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 650 m (up 7919.8% YoY). Sales on the other hand came in at Rs 8 bn (up 26.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

FDC LTD. 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of FDC LTD. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FDC LTD.. Also includes updates on the valuation of FDC LTD..

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Oct 17, 2019 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS